Temporary ex vivo inhibition of the expression of the human oncogene HER2 (NEU) by a triple helix-forming oligonucleotide

Cancer Research

Volumn 56, Issue 3, 1996, Pages 515-522

  Porumb, Korea ^a   Gousset, Hervé ^a   Letellier, Richard ^a   Salle, Valérie ^b   Briane, Dominique ^a   Vassy, Jany ^c   Amor Gueret, Mounira ^b   Israël, Lucien ^a   Taillandier, Eliane ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b Inst d'Oncol Cell et Molec Hum   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; OLIGONUCLEOTIDE;

ARTICLE; BREAST CANCER; COMPUTER MODEL; CONTROLLED STUDY; ELECTROPHORESIS; FLUORESCENCE MICROSCOPY; GEL ELECTROPHORESIS; GENE REPRESSION; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; NORTHERN BLOTTING; ONCOGENE NEU; PRIORITY JOURNAL; PROMOTER REGION; TATA BOX; TRIPLE HELIX;

BASE SEQUENCE; BLOTTING, NORTHERN; BREAST NEOPLASMS; ELECTROPHORESIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHATIDYLETHANOLAMINES; PURINES; RECEPTOR, ERBB-2; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 9044247860     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hélène, C , and Toulmé, J. J. Specific regulation of gene expression by antisense. sense and antigene nucleic acids. Biochim. Biophys. Acta. 1049. 99-125, 1990.
2. Cheng, Y. K., and Petitt, B M. Stabilities of double- and triple- strand nucleic acids. Prog. Biophys. Mol. Biol., 56: 225-257, 1992
3. Postel, E. H., Flint, S J , Kessler, D. J., and Hogan, M. E. Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels Proc. Natl Acad Sci USA, 88: 8227-8231, 1991.
4. Gee, J , and Miller, D M. Structure and applications of intermolecular DNA triplexes. Am. J. Med. Sci., 304: 366-372, 1992.
5. Maher, L. J , III. Inhibition of T7 RNA polymerase initiation by triple-helical DNA complexes Biochemistry, 31: 7587-7594, 1992.
6. Duval-Valentin, G., Thuong, N T , and Hélène, C Specific inhibition of transcription by triple helix-forming oligos. Proc. Natl. Acad. Sci. USA, 89: 504-508, 1992.
7. Young, S. L., Krawczyk, S. H., Matteucci, M D., and Toole, J. J. Triple helix formation inhibits transcription elongation in vitro. Proc Natl. Acad. Sci USA, 88: 10023-10026, 1991
8. Rando, R. F., De Paolis, L., Durland, R. H., Jayaraman, K., Kessler, D. J., and Hogan, M. E. Inhibition of T7 and T3 RNA polymerase directed transcription elongation in vitro Nucleic Acids Res., 22: 678-695, 1994.
9. McShan, W. M , Rossen, R. D., Laughter, A H., Trial, J. A., Kessler, D J., Zedengui, J. G., Hogan, M. E., and Orson, F. M Inhibition of transcription of HIV-1 in infected human cells by oligodeoxynucleotides designed to form DNA triple helices. J. Biol. Chem., 267: 5712-5721, 1992.
10. Porumb, H., Dagneaux, C., Letellier, R., Malvy, C., and Taillandier, E. Triple-helices targeted to the polypurine tract of a murine retrovirus. Gene (Amst), 149: 101-107, 1994.
11. Porumb, H , Bertrand, J. R , Paoletti, J , Vasseur, J J., Rayner, B., Imbach, J-L , and Malvy, C. 9-Aminoellipticine-derivatized α- and β-oligodeoxyribonucleotides targeted to the cap of β-globin mRNA, hybridization to natural and engineered mRNA, inhibition of translation and improved effect of tandem chains Antisense Res. Dev., 2: 279-292, 1992.
12. Morvan, F., Porumb, H., Degols, G. Lefebvre, I., Pompon, A., Sproats, B. S., Rayner, B , Malvy, C , Lebleu, B., and Imbach, J-L. Comparative evaluation of 7 modified oligonucleotide analogs as potential antisense agents. J. Med. Chem., 36. 280-304, 1993.
13. Porumb, H., Verspieren, P., Rayner, B., Imbach, J-L., Malvy, C., and Toulmé, J. J Measurement by thermoelution of the stability of duplexes formed by oligos and nitrocellulose-immobilized nucleic acids. Methods Mol. Cell. Biol., 4: 10-21, 1993.
14. Uchino, S., Tsuda, H., Maruyama, K., Kinoshita, T., Sasako, M., Saito, T., Kobayashi, M , and Hirohashi, S. Overexpression of c-erbB-2 protein in gastric cancer. Cancer (Phila.), 72. 3179-3184, 1993
15. Ross, J. S., Nazeer, T., Church, K., Amato, C., Figge, H , Rifkin, M. D., and Fisher, H. A. G. Contribution of HER2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostate carcinoma metastasis. Cancer (Phila.), 72: 3020-3028, 1993.
16. Isola, J. J., Holli, K , Oksa, H., Teramoto, Y., and Kalliomemi, O-P. Elevated erbB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer. Cancer (Phila.), 73: 652-658, 1994.
17. Oka, K., Nakano, T., and Arai, T c-erbB-2 oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix. Cancer (Phila.), 73: 668-671, 1994.
18. Dawkins, H J., Robbins, P. D., Smith, K. L , Sarna, M , Harvey, J M , Sterrett, G. F., and Papadimitriou, J. M. What's new in breast cancer? Molecular perspective of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease Pathol Res. Pract., 189: 1233-1252, 1993.
19. Tal, M., King, R., Kraus, M. H., Ullrich, A., Schlessinger, J., and Givol, D. Human HER2 (neu) promoter, evidence for multiple mechanisms for transcriptional initiation Mol. Cell Biol , 7: 2597-2601, 1987.
20. Mizuguchi, G , Kanei-Ishii, C , Takahashi, T., Yasukawa, T , Nagase, T , Horikoshi, M., Yamamoto, T., and Ishii, S. c-myb repression of c-erbB-2 transcription by direct binding to the c-erbB-2 promoter. J. Biol. Chem., 270: 9384-9389, 1995.
21. Ishii, S., Imamoto, F., Yamanshi, Y., Toyoshima, K., and Yamamoto, T. Characterization of the promoter region of the human c-erbB-2 proto- oncogene. Proc. Natl Acad Sci. USA, 84: 4373-4378, 1987
22. Bertram, J., Killian, M , Brysch, W., Schlingenslepon, K-H , and Knobe, M. Reduction of erbB2 gene product in mammary carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides. Biochem. Biophys. Res Commun., 200: 661-667, 1994.
23. Milligan, J. F., Krawczyk, S. H., Wadwani, S., and Matteucci, M. D. An anti-parallel triple helix motif with oligodeoxynucleotides containing 2′-deoxyguanosine and 7-deaza-2′-deoxyxanthosine. Nucleic Acids Res , 21. 327-333, 1993
24. Ebbinghaus, S. W , Gee, J. E , Rodu, B., Mayfield, C A., Sanders, G , and Miller, D. M., Triplex formation inhibits HER-2/neu transcription in vitro. J. Clin. Invest., 92: 2433-2439, 1993.
25. Ouali, M., Letellier, R , Sun, J. S., Akhebat, A., Adnet, F., Liquier, J , and Taillandier, E. Determination of G GC triple helix structure by molecular modeling and vibrational spectroscopy J. Am. Chem. Soc., 115: 4264-4270, 1993
26. Fasman, G D. (ed) CRC Handbook of Biochemistry and Molecular Biology, Ed. 3. Nucleic Acids, Vol 1, p 589. Boca Raton, FL CRC Press, 1975
27. Sen, D , and Gilbert, W. Guanosine quartet structures. Methods Enzymol , 211: 191-199, 1992.
28. Lavery, R. Structure and expression. In. W. K. Olson, M. H., Sarma, R. H Sarma, and M Sundaralingam (eds.), DNA Bending and Curvature, Vol. 3, pp. 191-211. Guiderland, NY: Adenine Press, 1988.
29. Dagneaux, C., Porumb, H., Letellier, R., Malvy, C , and Taillandier, E. Triple helix forming oligonucleotides used as drugs: an FTIR, Raman and molecular modelling study. J. Mol. Struct., 347: 342-350, 1995.
30. Felgner, J., Bennett, F., and Felgner, P. L. Cationic lipid-mediated delivery of polynucleotides. Methods: A Companion to Methods in Enzymology, 5: 67-75, 1993.
31. Gee, J. E., Revankar, G. R., Rao, T. S., and Hogan, M. E. Triplex formation at the rat neu gene utilizing imidazole and 2′-deoxy-6- thioguanosine base substitutions. Biochemistry, 34: 2042-2048, 1995.
32. Burgess, T. L., Fisher, E. F., Ross, S. L., Bready, J. V., Qian, Y-X., Bayewitch, L. A., Cohen, A. M., Herrera, C. J., Hu, S. S-F., Kramer, T. B., Lott, F. D., Martin, F. H., Pierce, G. F., Simonet, L., and Farrell, C. L. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. USA, 92: 4951-4055, 1995.
33. Dagneaux, C., Liquier, J., Scaria, P. V., Shafer, R. H., and Taillandier, E. FTIR spectroscopy structural study of triple helices obtained by targeting the d(GG-GAAAAGGG) oligomer. In: R H. Sarma and M. H Sarma (eds.), Structural Biology: The State of the Art. Proceedings of the Eighth Conversation, State University of New York, Albany, NY, pp 103-113. Guiderland, NY: Sarma Adenine Press, 1994.
34. Loke, S. L., Stein, C A., Zhang, X. H , Mori, K . Nakanishi, M., Subasinghe, C., Cohen, J. S , and Neckers, L. M. Characterization of oligo transport into living cells. Proc. Natl. Acad. Sci. USA, 86: 3474-3478, 1989.
35. Clarenc, J-P , Lebleu, B., and Leonetti, J-P. Characterization of the nuclear binding sites of oligodeoxyribonucleotides and their analogs. J. Biol. Chem., 269: 5600-5604, 1993.
36. Zhao, Q , Matson, S., Herrera, C., Fisher, E , Yu, H., and Kried, A. M. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligos. Antisense Res. Dev., 3: 53-66, 1993
37. Perez, J. R , Li, Y., Stein, C. A., Majumder, S , van Oorschot, A , and Narajanan. R Sequence-independent induction of Spl transcription factor activity by phosphorothioate oligodeoxynucleotides, Proc. Natl. Acad. Sci. USA, 91: 5957-5961, 1994
38. Zhao, X-Y., and Hung, M-C. Negative autoregulaaon of the neu gene is mediated by a novel enhancer. Mol. Cell. Biol , 12. 2739-2748, 1992.
39. Pasleau, F., Grooteclaes, M. and Gol-Winkler, R. Expression of c-erbB2 gene in BT474 human mammary tumor cell line, measurement of c-erbB2 mRNA half-life Oncogene, 8: 849-854, 1993.
40. Loke, S. L., Stein, C , Zhang, X., Avigan, M., Cohen, J., and Neckers, L. M. Delivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematopoietic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis. Curr. Trends Microbiol. Immunol , 141: 282-289, 1988
41. Spanakis. E. Problems related to the interpretation of autoradiographic data on gene expression using common constitutive transcripts as controls. Nucleic Acids Res., 21. 3809-3819, 1993.